How Donald Trump's disinfectant slip-up happened
Donald Trump was widely ridiculed for suggesting that injecting disinfectant into the lungs of coronavirus patients could wipe out the disease. Although the US President undoubtedly got the wrong end of the stick, it has emerged that one company really is hoping to trial a new ultraviolet light therapy which it claims can ‘disinfect’ the lungs. Colorado-based Aytu BioScience says it has carried out successful early tests of its ‘Healight’ technology which delivers intermittent ultraviolet light through a tube in the throat, directly to the lungs. The company itself terms the process ‘injectable disinfectant’ and it is likely to be the origin of President Trump’s comments. The ‘Healight’ therapy was first developed in 2017 by the Medically Associated Science and Technology (Mast) Program at the non-profit hospital Cedars-Sinai in Los Angeles. The company says the treatment has shown potential as an effective antiviral and antibacterial treatment while causing no damage to mammalian cell